Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The level of fibrosis among people with hep C strongly predicts their risk of developing serious liver disease or dying within five years.
Relying solely on a liver biopsy to diagnose cirrhosis among people with hepatitis C likely misses three in four cases of the advanced stage o...
Antiviral treatment for hepatitis B is linked to a reduced risk of hepatocellular carcinoma, the most common form of liver cancer.
Only one in five deaths of people with hepatitis C receives a listing of the virus on the death certificate.
People with hepatitis C virus die 15 years earlier and have a 12-times greater risk of death when compared with those without the virus.
A large study has underscored that the hepatitis B and C viruses disproportionately affect baby boomers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.